Professor Ricky Sharma is an international authority on the translation of radiobiology from the laboratory to the clinic, and on the multi-modality treatment of cancer with precision radiotherapy.
Prof Sharma is the vice president of clinical affairs at Varian, a Siemens Healthineers company. He is also an honorary consultant in clinical oncology at University College London (UCL) Hospitals, where he has a clinical practice in radiotherapy and chemotherapy. Prof Sharma has led a research team at UCL that translated discoveries in radiotherapy research to clinical trials to improve treatment for patients with cancer. He was chair of radiation oncology at UCL and a scientific group leader at the UCL Cancer Institute.
Prof Sharma was previously an associate professor at the University of Oxford, chair of working groups for NHS/NICE evaluations of novel radiotherapy treatments, and an honorary consultant in clinical oncology at Oxford University Hospitals.
He has over 200 publications in peer-reviewed scientific journals, including Lancet and Nature journals.
